Description
COVID-19 and influenza A/B may present with similar symptoms, so a reliable, efficient and accurate diagnosis is critical to guide treatment decisions and prevent further disease transmission.
The Trans SARS-CoV-2 & Influenza A/B Assay is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A virus and Influenza B virus nucleic acids.
Highlights
• 3 tests in 1 setup: SARS-CoV-2, Influenza A virus and Influenza B virus
• High sensitivity: Limit of detection (LoD) of 0.5 copies/μl
• High specificity: Evaluation for cross-reactivity with multiple species
• Fast workflow: Completed in 65 min (reaction setup & RT-PCR run)
• Minimized contamination : dUTP/ UNG used
• CE marked
Instruments
ABI 7500 and Bio-Rad CFX96 Real-Time PCR instrument
Sample Types
Pharyngeal swab or bronchoalveolar lavage specimens.
Clinical Applications
Up to 600,000 reactions of real time RT-PCR for SARS-CoV-2 detection have been successfully applied in clinical diagnosis with our key components.
Storage
Store the kit at -20±5℃ away from light for 12 months.
Shipping
Ship the kit at low temperature. Dry ice should be used for long-distance shipping; Avoid repeated freeze-thaw cycles (The number of freeze-thaw cycles should be fewer than 10).
PCR, RT-PCR, qPCR, qRT-PCR
Restriction/Modifying Enzymes
DNA Molecular Weight Standards
Cloning and Mutagenesis System
Nucleic Acid Purification
Next Generation Sequencing
Gene Expression
Protein Analysis
Protein MW Standards
Cell Culture and Detection
Exosome Related
Serum-free medium
Antibodies
Instruments
SARS-CoV-2 Detection
Residual DNA Detection
Animal Disease
